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Background: Motor impairment is a major consequence of spinal cord injury (SCI). Earlier studies have shown that
robotic gait orthosis (e.g., Lokomat) can improve an SCI individual’s walking capacity. However, little is known about
the differential responses among different individuals with SCI. The present longitudinal study sought to
characterize the distinct recovery patterns of gait impairment for SCI subjects receiving Lokomat training, and to
identify significant predictors for these patterns.
Methods: Forty SCI subjects with spastic hypertonia at their ankles were randomly allocated to either control or
intervention groups. Subjects in the intervention group participated in twelve 1-hour Lokomat trainings over one
month, while control subjects received no interventions. Walking capacity was evaluated in terms of walking speed,
functional mobility, and endurance four times, i.e. baseline, 1, 2, and 4 weeks after training, using the 10-Meter-Walking,
Timed-Up-and-Go, and 6-Minute-Walking tests. Growth Mixture Modeling, an analytical framework for stratifying
subjects based on longitudinal changes, was used to classify subjects, based on their gait impairment recovery
patterns, and to identify the effects of Lokomat training on these improvements.
Results: Two recovery classes (low and high walking capacity) were identified for each clinical evaluation from
both the control and intervention groups. Subjects with initial high walking capacity (i.e. shorter Timed-Up-and-Go
time, higher 10-Meter-Walking speed and longer 6-Minute-Walking distance) displayed significant improvements
in speed and functional mobility (0.033 m/s/week and–0.41 s/week respectively); however no significant change in
endurance was observed. Subjects with low walking capacity exhibited no significant improvement. The membership in
these two classes—and thus prediction of the subject’s gait improvement trajectory over time—could be determined
by the subject’s maximum voluntary torque at the ankle under both plantar-and dorsi-flexion contractions determined
prior to any training.
Conclusion: Our findings demonstrate that subjects responded to Lokomat training non-uniformly, and should
potentially be grouped based on their likely recovery patterns using objective criteria. Further, we found that the
subject’s ankle torque can predict whether he/she would benefit most from Lokomat training prior to the therapy.
These findings are clinically significant as they can help individualize therapeutic programs that maximize patient
recovery while minimizing unnecessary efforts and costs.
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A common focus during rehabilitation after spinal cord in-
jury (SCI) is on promoting improvements in functional
walking capacity. Fast and effective enhancement of gait
function can enhance a patient's independence, life sat-
isfaction, and subsequent reintegration into society as a
fully-participating member. Body weight support tread-
mill training (BWSTT) has been considered a primary
rehabilitative strategy for improving locomotion in pa-
tients with incomplete SCI [1,2]. BWSTT provides inten-
sive, task-specific repetitive walking training, promotes
supraspinal neuroplasticity involved in locomotion, and
consequently helps patients to regain their walking skills
[3-5]. While conventionally BWSTT is supplemented by
manual assistance from therapists, robotic-assisted BWSTT
has become widely used over the past decade to provide
symmetric walking training to support lower extremity
rehabilitation in patients with neurological movement
impairment. The most widely-used automated locomotor
training system is the Lokomat® (Hocoma AG, Volketswil,
Switzerland) [6,7]. Recent studies have shown that patients
can receive positive physical and psychological benefits
from Lokomat training [1,2,8-17], such as improved walk-
ing capacity [1,8-10], improved metabolic performance
[2,12], and increased activity in the cerebellum [15].
However, a recent review from Swinnen [18] has shown
that the effectiveness of Lokomat training remains con-
troversial, with some studies showing significant im-
provements in motor and walking performance after
Lokomat trainings, while others showing minimal changes
[18]. The authors and previous researchers have pointed
out that difficulty arises when translating these research
findings to the clinical setting because of the lack of a
control group in those studies [19]. The authors also
observe that the advantages of Lokomat training over
other types of locomotor trainings have yet to be fully
demonstrated.
In addition, the high variability in recovery pattern
among patients should be explicitly considered in the
analysis. Locomotor training, like any other intervention,
is not expected to affect all patients equally; instead, differ-
ent treatment responses are expected for different patient
subgroups. Many research studies, however, oversimplify
by assuming that all individuals are drawn from a single
population with a similar recovery pattern; pre-training
and post-training measures are then compared. This ap-
proach loses the heterogeneous response of patients to the
therapy program as well as the longitudinal information
describing the timeline of improvement—information that
should be considered when evaluating the efficacy of a
particular intervention. In fact, many studies involved with
locomotor training have reported results with a standard
deviation even larger than the sample mean, indicating
that the high inter-individual variance within their samplepopulation results in a less meaningful average value.
Thus, it is necessary to address these deficits by first iden-
tifying distinct latent classes within each sample and then
modeling the recovery patterns for each class separately.
In addition, pre-vs. post-training comparisons usually have
a lowered effect size and statistical power than longitu-
dinal tracking studies, because the error term has a larger
standard deviation than in other statistical models [20].
Recent statistical techniques such as Growth Mixture
Modeling (GMM) allow researchers to effectively recognize
this high inter-individual variance, and to model the growth
pattern of a longitudinal recovery procress. The inclusion
of additional time points between the pre-and post-training
evaluations can help elucidate the training effect on gait im-
pairment, and further can dramatically improve the statis-
tical power in situations where increasing sample size is not
feasible due to costs and patient availability [20].
In the present study, rather than performing a pre-vs.
post-training comparison within one experimental treat-
ment group, we examined in detail the growth trajectory
of three aspects of gait impairment (speed, functional
mobility, and endurance, as evaluated by typical clinical
measures) for subjects in an intervention group receiv-
ing Lokomat training and those in a control group who
received no intervention. Instead of assuming that all
subjects are drawn from a single population, we object-
ively classified the subjects into distinct subgroups based
on their growth trajectory of walking capacity, and then
modeled the effect of Lokomat training for each sub-
group. Finally, we evaluated whether baseline measure-
ments of neuromuscular and clinical performance could
serve as statistical predictors for these recovery patterns.
In particular, we hypothesized that ankle strength—mea-
sured in terms of maximum voluntary dorsiflexion and
plantarflexion torque—could predict the recovery trend
for these clinical evaluations.
Method
Study participants
Forty incomplete SCI subjects (twenty-seven males, thir-
teen females) with spastic hypertonia at their lower ex-
tremities participated in this single-center, unblinded, and
randomized study (Table 1). Each subject was assigned ei-
ther to the control or intervention (Lokomat training)
group according to a permuted block randomization de-
sign. All subjects were injured within their cervical or
upper thoracic (superior to T10) vertebrae.
All subjects gave informed consent according to the po-
licies of the Institutional Review Board of Northwestern
University.
Lokomat training
The Lokomat was used to train subjects in pre-
programmed physiological gait pattern. The system uses a
Table 1 Baseline characteristics of SCI patients (n = 40) in the Lokomat and control group (mean ± standard deviation),
including age, post-injury time, ankle joint tested, gender ratio, walking index for spinal cord injury (WISCI II),
plantarflexion MVC torque (Tp) and dorsiflexion MVC torque (Td)















42.2 ± 12.6 8.9 ± 9.9 8 right/ 12 left 7/13 15 ± 4 25.5 ± 16.8 11.2 ± 6.2 6/14
Control
(n = 20)
49.7 ± 7.0 7.5 ± 5.5 7 right/ 13 left 6/14 16 ± 4.5 28.7 ± 18.6 13.9 ± 8.2 6/14
Note: No significant difference was found for any baseline measure between groups (P = NS).
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synchronized treadmill while a harness system dynamic-
ally adjusts the amount of body-weight support. Gait pa-
rameters, such as the range of motion of the hip and knee
joints, walking speed, body weight support, and guidance
force, were adjusted in real-time by the physical therapist.
Each subject received a one-hour training session three
times per week for four consecutive weeks; as it took 15–
20 minutes to set up the subject, the gait training lasted
up to 45 minutes per session. The goal of the Lokomat
training was to increase the walking speed and decrease
guidance force and body-weight support over the twelve
training sessions based on the subject's improvement. In
each session, the training speed was increased gradually
from the minimum allowed by the machine to a peak
magnitude (up to 3.4 km/hr) where the subject could
maintain gait quality without feeling fatigued. The guid-
ance force was then decreased from full assistance of the
robot, until the subject was no longer able to maintain the
set speed (low to 20% assistance) and the body-weight
support, customized to the individual subject’s ability. The
same therapist provided all trainings for a given subject.
Outcome measures: walking capacity
Walking capacity was assessed during the training regi-
men using three standard clinical evaluations: 10-Meter-
Walking Test (10MWT) [21], Timed-Up-and-Go (TUG)
[22], and 6-Minute-Walking Test (6MWT) [23]. Subjects
were evaluated four times for their overground walking
capacity: at the baseline (i.e., prior to any Lokomat trai-
ning), and after 1, 2, and 4 weeks of training. Subjects
were permitted to use assistive devices and braces dur-
ing the tests. Harness systems, parallel bars, and other
support systems were not permitted. All tests for an in-
dividual subject were measured by the same examiner.
The 10MWT was used to evaluate walking speed over
a short distance by measuring the time spent walking
over a distance of 10 meters. The 10MWT has been
rated as the test that provides the most valid measure of
walking speed improvement [24].
The TUG was used to evaluate the functional recovery
by measuring time taken by the subject to stand up from
an armed chair, walk three meters, turn around, and sitback in the chair. It has been used to evaluate func-
tional mobility and balance for various movement dis-
orders [25-27].
The 6MWT test was used to assess walking endurance
by measuring the distance walked in six minutes. It has
been widely used to evaluate the response to therapeutic
treatment for stroke and spinal cord injury, and is be-
lieved to provide a more accurate measure of daily activ-
ity than other walking tests [28].
These timed walking tests have been confirmed for
their high concurrent and discriminant validity for SCI
individuals [23,29], and are widely used as guidelines to
both evaluate functional walking capacity and aid in the
interpretation of clinical research results.
Muscle strength: walking capacity predictor
The isometric torque resulting from the maximum volun-
tary contraction (MVC) at the ankle joint was measured
after each subject finished all required clinical evaluations.
Prior to any testing, the Modified Ashworth Score (MAS)
was evaluated at each ankle joint. The ankle joint with the
highest modified Ashworth scale and lowest maximum
voluntary contraction (both conditions often occurred on
the same side) was chosen for the MVC evaluation. Sub-
jects were then seated in an adjustable chair with the
ankle attached to a customized shoe mounted securely
to a rigid plate. The trunk and thigh were strapped to
the chair to minimize their contributions to ankle and
foot movement. Subjects were then instructed to generate
(MVC) in the dorsiflexion (Td) and plantarflexion (Tp) di-
rections, using only their ankle joint, while the ankle joint
was held fixed at 90° and the knee joint was held at 120°.
During the experiment, the subject exerted a maximum
force by pressing down (plantarflexion) or pulling up
(dorsiflexion) against the stationary foot plate, which was
in turn attached to a six-axis torque transducer (JR3 Inc.,
Woodland, CA). The subjects were instructed to practice
exerting the MVC torque without using their knee and
hip joints by minimizing the EMG activity in quadriceps
and hamstring muscles. Electromyography (EMG) activity
from the tibialis anterior, gastrocnemius, quadriceps and
hamstring muscles was monitored using bi-polar surface
electrodes (Ag-Ag/Cl type, Delsys, Boston MA); trials with
Figure 1 10MWT speed as a function of training week. Mean ± SE
for each latent class shown. The linear regression line for Class 2 in the
Lokomat group was obtained from GMM. No other changes in 10MWT
speed with time were significant.
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peated. Two trials were performed for each evaluation; the
trial with the higher peak torque was chosen for the sub-
sequent data analysis.
Data analysis: recovery pattern identification and prediction
Growth Mixture Modeling (GMM) was used to subdivide
participants into multiple latent classes based on the re-
covery patterns (i.e., the change over time) of their walking
measures, and subsequently inspect gait improvement
within each class. Logistical regression was then applied to
identify potential predictors for subject class membership.
Recovery pattern identification using GMM
GMM is one type of longitudinal mixture model, and has
been widely used to analyze data that exhibits heterogen-
eity in developmental pathways [30-37]. GMM assumes
that a given sample of subjects can be divided into a finite
number of groups, each of which is comprised of subjects
with similar recovery patterns. That is, all subjects within
a given class were assumed to exhibit similar changes over
time. In effect, GMM is analogous to a clustering tech-
nique, e.g., k-means, but with consideration of multiple
observations over time. The intervention effect was then
be modeled within individual subgroups and compared
with control or other treatment groups. A two-step GMM
procedure was employed in this study. Step 1 classified
the control and intervention groups separately, based
on the measured growth trajectories of their clinical
evaluations. A mixed-effects model (random coefficient
regression) was then used to determine if the trajectories
showed significant change over time. Step 2 involved a
joint analysis to examine the training effect on walking
capacity. For Class 1, the difference in the rates of change
between the control and intervention groups was com-
pared using the regression slopes; the same procedure was
then used for Class 2 [37]. The quality of the resulting
classification was evaluated by the posterior probabilities
of subject class membership and by the Bayesian informa-
tion criteria.
Prediction of recovery patterns at baseline using logistic
regression analysis
The class membership of subjects in each treatment group
was correlated with the latent variables (potential predic-
tors) using logistic regression [38-40], in order to deter-
mine whether injury level, age, gender, walking index for
spinal cord injury (WISCI II) and muscle strength (MVC
torque at the ankle joint) evaluated at the baseline could
predict clinical assessments of functional improvement
over the subsequent four weeks. Such an analysis can help
to discover potentially-causal relationships between the
predictors and functional improvement.The group allocation, i.e., control and Lokomat training,
was concealed (blinded) to the statistician. The GMM
analysis was performed in the R statistical package V 2.12
(open source software, www.r-project.org), while the lo-
gistic regression was performed using SAS v 9.0 (SAS
Institute, Cary NC). Statistical tests with a P < 0.05 were
considered significant.
Results
Recovery patterns of gait impairment measures
GMM was used to identify the growth trajectories for
both control and intervention groups, and to identify the
effect of training on these classes. Figures 1 and 2 show
the mean trajectory for each class. Table 2 summarizes
the statistical results from the GMM analysis.
Latent class identification
Control group The growth trajectory for each of the
three clinical measures was examined by GMM over the
4-week training period. Two distinct growth patterns
were identified for each walking measure (Figures 1 and
2, Table 2). The latent classes that included subjects with
longer 10MWT and TUG times and shorter 6MWT dis-
tances at baseline (i.e., the initial test) were defined as
the low walking capacity classes (Class 1). Similarly, the
latent classes for subjects with shorter 10MWT and
TUG times and a longer 6MWT distance were defined
as the high walking capacity classes (Class 2).
Intervention group Similar to the control group, two
classes of growth pattern were identified for each clinical
evaluation, corresponding to low and high walking cap-
acity at baseline (Figures 1 and 2, Table 2).
Subject class membership agreed across the different
clinical evaluations for both groups. The average poster-
ior probabilities of class membership were 0.99 for each
walking test, suggesting low classification error.
Figure 2 TUG time as a function of training week. Mean ± SE in
each latent class shown. The linear regression line for Class 2 in
Lokomat was obtained from GMM. Note that the ordinate scales are
different between Class 1 and Class 2, due to their large difference
in standard errors.
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For the 10MWT test, the GMM analysis considering
joint groups found a significant beneficial training effect
for subjects with a high walking capacity (P = 0.02). In
the Lokomat group, subjects in Class 2 increased their
walking speed at a rate of 0.033 m/s/week (P = 0.01).
Subjects in Class 1 did not show significant benefit from
the Lokomat training (P = NS).
For TUG, the GMM analysis of joint groups found a
beneficial training effect on subjects with high walking
capacity (P = 0.05). Subjects in Class 2 of the Lokomat
group decreased their time at a rate of 0.41 s/week (P =
0.02). Subjects in Class 1 did not show significant bene-
fit from the Lokomat training (P = NS).
For 6MWT, the training effect was not found to be sig-
nificant for subjects from either the high or low walking
capacity groups, based on the GMM analysis (P =NS).
The change over time for each clinical measure was
not significant for any latent class in the control group
(P =NS).Table 2 Illustration of classification and joint group analysis f
Latent
class







10MWT Class 1 8 0.233 ± 0.050 m/s 8
Class 2 12 0.829 ± 0.047 m/s 12
TUG Class 1 8 61.27 ± 9.16 s 6
Class 2 12 14.67 ± 0.81 s 12
6MWT Class 1 6 80.77 ± 18.33 m 6
Class 2 12 245.66 ± 21.02 m 12
*Indicates p < 0.05, ** ndicates p < 0.01.
Note that in the control group two subjects who could not perform the 6MWT eval
intervention group who could not perform the TUG or 6MWT evaluations belongedPrediction of gait impairment recovery patterns by
mvc torque
Figure 3 shows the relationship between baseline MVC
torque and subject class membership for the 10MWT
evaluation in the Lokomat group. Table 3 presents the
results of the logistic regression to determine whether
MVC torque is able to predict subject class membership
for the Lokomat group.
As the plantarflexion MVC torque (Tp) had overlapping
ranges for the two latent classes for each clinical evalu-
ation, logistic regression was used to inspect the effects of
Tp on the subject class membership, using Class 1 as the
reference. For the 10MWT evaluation, subjects with Tp >
18.3 Nm were more likely to be members of Class 2 than
subjects with Tp ≤ 18.3 Nm. For each unit increase in Tp,
the odds that a subject belonged to Class 2 increased by
18% (P < 0.01). For the TUG test, it was shown that sub-
jects with Tp > 17.5 Nm had a higher likelihood of mem-
bership in Class 2 (P < 0.01). For 6MWT, subjects with
Tp > 16.1 Nm were more likely to belong to Class 2 than
subjects with Tp ≤ 16.1 (P < 0.01).
A similar logistic regression was performed for the
dorsiflexion MVC torque (Td). It was shown that subjects
with Td > 9.5 Nm had a higher likelihood of Class 2 mem-
bership than subjects with Td ≤ 9.5 Nm for both the
10MWT and TUG evaluations (P < 0.01). For the 6MWT,
subjects with Td > 8.9 Nm were more likely to belong to
Class 2 than subjects with Td ≤ 8.9 Nm (P < 0.01).
Figure 4 shows the predicted probability of a subject
to belong to the high walking capacity class (Class 2),
based on their measured Tp or Td, assuming pooled
subjects of both the control and intervention groups. It
further confirmed that Tp and Td were significant pre-
dictors for walking-capacity classification (P < 0.01).
Other possible factors, including injury level, Modified
Ashworth Scale score, gender, age and post-injury time
were found not to have any significant effect on the class
membership for any clinical evaluation (P =NS for all).rom GMM for control and intervention groups





Difference in rate of change
between two groups (P-value)
0.124 ± 0.024 m/s 0.007 m/s/week 0.009
0.838 ± 0.083 m/s 0.033 m/s/week** 0.029*
70.49 ± 14.56 s −3.35 s/week −4.55
15.04 ± 1.12 s −0.41 s/week** −0.32*
42.27 ± 9.21 m 0.58 m/week 0.79
279.40 ± 28.46 m 1.60 m/week 2.28
uation belonged to Class 1 for 10MWT and TUG, while two subjects in the
to Class 1 for 10MWT.
Figure 3 Relationship between plantarflexion (Tp, panel A) torque and dorsiflexion (Td, panel B) MVC torque and subject class
membership, for the 10MWT evaluation in the Lokomat group. Note: in each boxplot, the bounds of the box denote the first and third
quartiles, while the two whiskers denote the minimum and maximum values.
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The longitudinal growth pattern of gait impairment for
two groups of SCI subjects—control and intervention—
over four weeks of ongoing Lokomat training, was investi-
gated and analyzed with the GMM. Two classes of growth
trajectory in each clinical evaluation were identified for
both the control and intervention groups, representing
subgroups with low and high walking capacity. The two
latent classes responded to the Lokomat training differ-
ently; subjects with high walking capacity presented sig-
nificant and consistent improvements in walking speed
and balance with time, while subjects with low walking
capacity exhibited no such significant improvement. Inter-
estingly, the results indicated that the baseline (i.e. pre-
training) measures of MVC torque (Td and Tp) could pre-
dict the differential treatment response, i.e., subjects with
high Tp and Td were more likely to have both high walk-
ing capacity and receive significant benefit from Lokomat
training. These findings can help clinicians to identify the
subgroups of individuals with incomplete SCI in terms of
their current and potential walking capacity and to esti-
mate the differential treatment effects of the Lokomat
intervention on their recovery progress.
The effect of lokomat training on walking improvement
The twelve sessions of Lokomat training for SCI subjects
improved their functional ambulation in a selective manner.Table 3 Logistic regression results used to assess whether Tp
Lokomat group
Logistic regression of class membership on
Odds ratio [95% CI] P-value Baseline T
Class 2 in 10MWT 1.18 [1.05, 1.41] P < 0.01 >18
Class 2 in TUG 1.16 [1.03, 1.39] P < 0.01 >17
Class 2 in 6MWT 1.18 [1.04, 1.45] P < 0.01 >16
The relation between baseline torque (Tp or Td) and patient class membership was
reference group.Subjects with low walking capacity did not show significant
improvements. By contrast, subjects with a high walking
capacity at baseline presented a consistent linear trend
in time for both speed and functional balance over the
4-week training period. Our average improvement in
10MWT speed (0.132 m/s) indicates that the 12-session
Lokomat training program can improve the walking
speed for SCI subjects with high walking capacity; this
improvement exceeds the threshold established by Lam
[41] (viz. 0.13 m/s) for significant clinical change in
10MWT. Our results agree with previous reports that
Lokomat training improves the overground walking
capacity [1,9,15,42], and that subjects with less control
impairment achieve greater improvement [19].
While the 10MWT, TUG and 6MWT evaluate different
aspects of gait impairment, they have been shown to be
highly-correlated in the walking validity test [23,29,41,43,44].
Despite this, surprisingly we observed no significant change
in the 6MWT, whereas the 10MWT and TUG improved
significantly. Such a discrepancy was also reported in a
similar training for the stroke population [45]. By contrast,
other studies reported improvements in endurance for SCI
subjects who were provided with two months or more of
Lokomat training as well as supplementary pharmaceutical
intervention [1,10]. Thus, lack of significant improvement
in 6MWT in our study could be due to the lower number
of training sessions in our study than others. In particular,or Td could predict patient class membership in the
Tp Logistic regression of class membership on Td
p (Nm) Odds ratio [95% CI] P-value Baseline Td (Nm)
.3 2.20 [1.26, 8.22] P < 0.01 >9.5
.5 2.18 [1.23, 8.22] P < 0.01 >9.5
.1 2.10 [1.28, ∞] P < 0.01 >8.9
measured by the odds ratio with Class 1 of each clinical measure as the
Figure 4 Logistic regression results to determine ability of Tp
(panel A) and Td (panel B) to predict class membership.
Regression indicates whether MVC torque predicts whether a
subject is in the high walking capacity class (i.e., Class 2) for pooled
subjects from both groups. The predicted probability curve
(solid line) and 95% confidence limits (dashed line) are shown.
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the individuals in the low-capacity class, as 4-weeks may be
too little to effect the necessary neuroplasticity to improve
walking function. Further, our walking endurance test was
performed at a self-selected speed that the subject felt was
most comfortable. Therefore, trial-to-trial variations during
the clinical evaluations might be much higher than the im-
provements received from the training, i.e., an individual
subject did not necessarily perform the clinical evaluations
at his/her maximum effort level, complicating the detection
of the training effects.
Need for classification of recovery patterns
A few other studies in the literature have classified their
participants prior to other analyses, based on a priori or
empirical considerations. A walking validity test by van
Hedel et. al. grouped subjects into low and high capacity
based on their walking index score prior to performing the
correlation analysis [23]. Correlation between walking tests
and WISCI II score was found to be significant for sub-
group with high walking function (WISCI II > 10), while it
was little for subgroup with WISCI II ≤ 10. A study byField-Fote et. al. also classified subjects into two subgroups
by their walking speeds [9]. They found that subjects with
slower initial walking speed achieved higher improvement
in walking speed than those with faster initial walking
speeds, in contrast with our finding. The discrepancy could
be due to the fact that they used a limited number of
subjects who were randomly assigned to 4 different body-
weight-support assisted-stepping groups, including tread-
mill training with manual assistance, robotic assistance,
stimulation, and overground training with stimulation.
Each slower- and faster- initial walking group included a
combination of subjects who received different types of
training with different mechanisms of actions, making the
interpretation of the effects of Lokomat alone difficult.
By contrast, the GMM analysis in this study classified
subjects with the same training in terms of their growth
trajectories using a rigorous statistical technique, which
provides objective evidence for the validity of classifying
subjects into subgroups prior to other statistical analyses.
Further, it can be expected that the recovery manner
of SCI subjects during neurorehabilitation might present
more complex growth patterns than those found in the
current study, e.g., different numbers of latent classes for
different clinical tests, and inconsistencies in the class
membership between the various clinical evaluations.
Classification with objective criteria, such as that pro-
vided by GMM, can provide a robust and repeatable
analytical framework to reveal distinct subgroups which
exhibit substantial differences between subgroups but
maintain high within-group similarities.
Prediction of effect of lokomat training on improving
walking capacity
To determine the extent to which the recovery pattern
of walking capacity can be predicted based on baseline
measures, the ability of MVC torque (Td and Tp) to de-
termine subject classification was assessed. Our results
showed that subjects with a larger Tp or Td had a
higher likelihood of membership in the high walking
capacity group for each clinical test, and thus to receive
significant training benefit. Such findings indicate that
this quantitative measurement of ankle MVC dorsiflex-
ion and plantarflexion torque can potentially be a fast
and reliable clinical assessment that can be used to iden-
tify which subjects are most likely to make significant
progress during a one-month Lokomat training regimen
prior to the start of training. The ability of other kinetic
and kinematic variables to predict gait recovery, such as
knee and hip strength, as well as range of motion of
lower limb joints, will be investigated in future studies.
Although clinical assessments of gait impairment, such
as the 10MWT, TUG, and 6MWT assessments, have
been well-accepted by physicians, their applications are
also limited by the requirement of necessary time and
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to the choice of route for the 6MWT assessment, and the
motivation for subjects to perform the tests [28]. By
contrast, our study implies that ankle MVC provides an
objective measurement that can be part of a routine office
visit with a physician.
Our study also can lend insight into the role of muscle
strength on gait impairment. In particular, we expect that
weakness of the anterior tibialis (TA) and the gastrocne-
mius (GS) are likely related to gait impairment. This is ex-
pected due to the role played by the neuromuscular
properties of the spastic ankle during ambulation. For ex-
ample, walking capacity after SCI is commonly impaired
by equinus foot, partially due to spasticity and weakness of
the ankle dorsiflexors. Spasticity of ankle plantarflexors has
reciprocal inhibitory effects on TA activity, and additionally
causes spastic hyperactivity of GS and hypoactivity of TA.
Both of these can reduce the voluntary contraction cap-
acity of these muscles and contribute to equinus foot and
walking impairment. It has been shown that, in addition to
improving walking capacity, Lokomat training can signifi-
cantly reduce the neuromuscular abnormalities associated
with spasticity and may result in increased ankle MVC
torque [46]. Such an explanation is further supported by
the finding that the improvements in muscle strength for
SCI subjects with spastic hypertonia at the ankle joint are
mainly due to reductions in reflex stiffness [47,48]. Our re-
sults extend those findings by showing that MVC torque
measured at baseline can be a significant predictor for the
recovery pattern of SCI gait impairment.
Study limitations
It was not feasible to blind the researchers who performed
the tests to the group allocation since they needed to stay
with the subjects during the Lokomat trainings and ex-
perimental protocols. All tests and trainings for each indi-
vidual subject were performed by the same researcher;
however, since this longitudinal study occurred over a
span of multiple years, it was not feasible for one re-
searcher to test all subjects. The effects of these limita-
tions on the results are unclear.
Directions for future research
Although several studies have compared the therapeutic ef-
fects of Lokomat to other physical interventions, it is our
interest to use the advanced techniques that we used in
this study to compare the therapeutic effects of this rela-
tively new physical intervention to more well-established
pharmacological interventions that are developed to im-
prove function and reduce clinical impairments. Deter-
mining whether the Lokomat training is equally or more
effective than pharmacological treatments is clinically
significant, as some patients are able to tolerate physical
interventions but not medications, while for others theopposite case is true. Thus, it is important to quantify
outcomes for different types of interventions in order
to provide optimal treatments. Furthermore, since
the mechanisms and actions of these interventions are dif-
ferent, applying a combination of these interventions may
provide benefits superior to the individual treatments.
Conclusions
Overall, our study indicates that Lokomat training can
be an effective physical intervention for SCI subjects
with high walking capacity, but not for those with low
walking capacity. Further, our findings indicate that the
MVC torque measured prior to training may be an ob-
jective and reliable tool to predict which subject groups
can benefit the most from Lokomat training, prior to be-
ing assigned to that therapy. Such an approach can allow
clinicians to prescribe a therapeutic and rehabilitation
plan that best optimizes an individual’s recovery out-
comes while minimizing unnecessary effort and costs.
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